Deutsche Bank Ag\ Novo Nordisk A S Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Novo Nordisk A S stock. As of the latest transaction made, Deutsche Bank Ag\ holds 149,418 shares of NVO stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

149,418

Previous 151,920 1.65%

Holding current value

$12.7 Million

Previous $21.7 Million 17.96%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $297,913 - $363,840	-2,502 Reduced 1.65%	149,418 $17.8 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $195,599 - $234,174	1,594 Added 1.06%	151,920 $21.7 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $631,346 - $840,393	6,183 Added 4.29%	150,326 $19.3 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $592,953 - $712,314	6,755 Added 4.92%	144,143 $14.9 Million
Q3 2023 Nov 09, 2023	SELL	$90.94 - $199.54 $24.2 Million - $53.2 Million	-266,527 Reduced 65.99%	137,388 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $54 Million - $59.7 Million	345,899 Added 596.21%	403,915 $65.4 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $73,581 - $88,481	556 Added 0.97%	58,016 $9.23 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $815,272 - $1.08 Million	7,950 Added 16.06%	57,460 $7.78 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $8.5 Million - $10.4 Million	-89,227 Reduced 64.31%	49,510 $4.93 Million
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $7.55 Million - $8.91 Million	73,160 Added 111.56%	138,737 $15.5 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $202,306 - $244,549	2,173 Added 3.43%	65,577 $7.28 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $58,678 - $71,652	-612 Reduced 0.96%	63,404 $7.1 Million
Q3 2021 Nov 04, 2021	BUY	$84.42 - $106.62 $862,856 - $1.09 Million	10,221 Added 19.0%	64,016 $6.15 Million
Q2 2021 Aug 11, 2021	SELL	$67.66 - $84.76 $26,049 - $32,632	-385 Reduced 0.71%	53,795 $4.51 Million
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $706,410 - $798,687	-10,534 Reduced 16.28%	54,180 $3.65 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $586,190 - $677,115	-9,175 Reduced 12.42%	64,714 $4.52 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $1.32 Million - $1.46 Million	-20,721 Reduced 21.9%	73,889 $5.13 Million
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $1.03 Million - $1.2 Million	17,623 Added 22.89%	94,610 $6.2 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $131,316 - $171,990	2,655 Added 3.57%	76,987 $4.64 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $12 Million - $14 Million	-240,580 Reduced 76.4%	74,332 $4.3 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $345,092 - $387,848	-7,259 Reduced 2.25%	314,912 $16.3 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $807,033 - $905,002	17,248 Added 5.66%	322,171 $16.4 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $3.13 Million - $3.56 Million	67,603 Added 28.49%	304,923 $15.9 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $7.17 Million - $8.15 Million	-172,546 Reduced 42.1%	237,320 $10.9 Million
Q3 2018 Dec 21, 2021	BUY	$46.76 - $51.24 $3.59 Million - $3.93 Million	76,749 Added 23.04%	409,866 $19.3 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $24.2 Million - $26.5 Million	-518,047 Reduced 60.86%	333,117 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $19 Million - $21.6 Million	429,271 Added 101.75%	851,164 $39.3 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $4.53 Million - $5.43 Million	93,478 Added 28.46%	421,893 $20.8 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $1.5 Million - $1.7 Million	-31,563 Reduced 8.77%	328,415 $17.6 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $14.8 Million - $17.7 Million	359,978	359,978 $17.3 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account